Vimarsana
Biggest News Aggregation in the World

Alex Khan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alex Khan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alex Khan Today - Breaking & Trending Today

KGO ABC7 News 1100AM October 10, 2013 - Vimarsana News

KGO ABC7 News 1100AM October 10, 2013

That means that police did not find a gunman at the hall. This is the good news. It started this morning when a student reported to police he saw a gunman rooming the hallway of sweeney hall. He reported it to the police. The police told students and faculty to shelter in place and locked down the building. We spoke to a Police Spokesman before the all clear. Here is what she said. We have teams from san jose and the University Police sweeping the building. As you can imagine, this will take a while to go room to room, closet to closet and check every door for the individual. We will go back t...

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - Vimarsana News

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

VANCOUVER, Wash. and NEW YORK, May 28, 2024 -- Absci Corporation , a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Goldman Sachs...

Absci Announces Pricing of Public Offering of Common Stock - Vimarsana News

Absci Announces Pricing of Public Offering of Common Stock

VANCOUVER, Wash., Feb. 27, 2024 -- Absci Corporation , a data-first generative AI drug creation company, today announced the pricing of an underwritten public offering of 16,700,000 shares of its...

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI - Vimarsana News

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

IND submission expected in Q1 2025; Phase 1 trials anticipated to initiate shortly afterVANCOUVER, Wash. and NEW YORK, Feb. 21, 2024 -- Absci Corporation , a data-first generative AI drug creation...

Absci to Participate in Upcoming Investor Conferences - Vimarsana News

Absci to Participate in Upcoming Investor Conferences

VANCOUVER, Wash. and NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the